Pancreatic Cancer Clinical Trials in Pittsburgh, Pennsylvania
5 studies are recruiting for pancreatic cancer in Pittsburgh, Pennsylvania right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.
Search these by distance from you
Studies now recruiting
-
Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
The purpose of this study is to evaluate the safety and efficacy of a novel RAS(ON) inhibitor compared to standard of care (SOC) observation only.
- Stage
- Phase 3
- Ages
- 18 and older
- Site
- UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania
- Locations
- 74 in total
- Run by
- Revolution Medicines, Inc.
-
A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer
Pancreatic cancer is difficult to diagnose early. By the time people have been diagnosed, the cancer has usually spread to other parts of the body (metastatic). The standard treatment is chemotherapy, but other treatments are needed to improve outcomes in people with pancreatic cancer. The first tr…
- Stage
- Phase 3
- Ages
- 18 and older
- Site
- AGH Singer Research Institute, Pittsburgh, Pennsylvania
- Locations
- 62 in total
- Run by
- Astellas Pharma Global Development, Inc.
-
Distance-Based Exercise to Preserve Function and Prevent Disability
This clinical trial studies whether an exercise program can be successfully delivered to patients receiving treatment for cancer through virtual sessions and allow patients to exercise in their own home. Treatments for cancer can cause side effects such as fatigue and loss of strength. These side e…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania
- Locations
- 18 in total
- Run by
- Alliance for Clinical Trials in Oncology
-
The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
The Multi-OutcoMe EvaluatioN of radiation Therapy Using the Unity MR-Linac Study (MOMENTUM) is a multi-institutional, international registry facilitating evidenced based implementation of the Unity MR-Linac technology and further technical development of the MR-Linac system with the ultimate purpos…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Allegheny Health Network, Pittsburgh, Pennsylvania
- Locations
- 18 in total
- Run by
- UMC Utrecht
-
Pancreatic Adenocarcinoma Gene Environment Risk Study
After informed consent, participants will be asked to complete a medical/family history questionnaire and provide a blood sample. Some participants may also be asked to provide a urine sample. Individuals undergoing procedures that require collection of biological samples for clinical purposes may …
- Stage
- Not phased
- Ages
- 18 and older
- Site
- University of Pittsburgh, Pittsburgh, Pennsylvania
- Run by
- University of Pittsburgh
How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.
What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.
Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.